Integrated single‐cell transcriptomics reveals miR‐941 targets CLDN4 to inhibit malignant progression of thyroid cancer through the PI3K/AKT signaling pathway
Abstract Claudin‐4 (CLDN4), a key tight junction protein, has been implicated in tumor progression; however, its functional role and regulatory mechanisms in thyroid cancer remain unclear. This study aimed to investigate the contribution of CLDN4 to malignant progression and its interaction with the tumor–immune microe...